Cargando…

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations

Systemic sclerosis (SSc) has been classically linked to interstitial lung disease (ILD) development, often in association with specific SSc autoantibodies. In the present report, we aimed to estimate the prevalence of SSc autoantibodies in 60 seropositive RA and 41 primary SS patients complicated or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koulouri, Vasiliki, Bakasis, Athanasios-Dimitrios, Marketos, Nikolaos, Tavernaraki, Kyriaki, Giannelou, Mayra, Moutsopoulos, Haralampos M., Mavragani, Clio P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816776/ https://www.ncbi.nlm.nih.gov/pubmed/36619654 http://dx.doi.org/10.1016/j.jtauto.2022.100183

Ejemplares similares

Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca Complaints
por: Marketos, Nikolaos, et al.
Publicado: (2023)

The Role of Novel Autoantibodies in the Diagnostic Approach and Prognosis of Patients with Raynaud’s Phenomenon
por: Koulouri, Vasiliki, et al.
Publicado: (2020)

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
por: Skarlis, Charalampos, et al.
Publicado: (2021)

Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
por: Fragkioudaki, Sofia, et al.
Publicado: (2016)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients
por: Papageorgiou, Aristea, et al.
Publicado: (2015)

COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
por: Gravani, Fotini, et al.
Publicado: (2015)

COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
por: Argyriou, Evangelia, et al.
Publicado: (2021)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

A case of antisynthetase syndrome
por: Mavragani, Clio P., et al.
Publicado: (2020)

COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome
por: Fragkioudaki, Sofia, et al.
Publicado: (2017)

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
por: Nezos, Adrianos, et al.
Publicado: (2021)

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome
por: Flessa, Christina-Maria, et al.
Publicado: (2022)

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015)

Is Sjögren's syndrome a retroviral disease?
por: Sipsas, Nikolaos V, et al.
Publicado: (2011)

Polyarthritis and Psoriasiform Skin Lesions following Pembrolizumab Therapy
por: Koulouri, Vasiliki, et al.
Publicado: (2021)

Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
por: Mavragani, Clio P., et al.
Publicado: (2015)

Anxiety and Extraversion in Lupus-Related Atherosclerosis
por: Giannelou, Maira, et al.
Publicado: (2018)

Editorial: Management of Sjögren's Syndrome
por: Alunno, Alessia, et al.
Publicado: (2022)

Sjogren’s Syndrome: Recent Updates
por: Skarlis, Charalampos, et al.
Publicado: (2022)

Cardiovascular Magnetic Resonance Demonstrates Myocardial Inflammation of Differing Etiologies and Acuities in Patients with Genetic and Inflammatory Myopathies
por: Markousis-Mavrogenis, George, et al.
Publicado: (2023)

Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome
por: Skarlis, Charalampos, et al.
Publicado: (2022)

Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis
por: Bournia, Vasiliki-Kalliopi K, et al.
Publicado: (2010)

Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View
por: Rozis, Meletios, et al.
Publicado: (2021)

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients
por: Nezos, Adrianos, et al.
Publicado: (2018)

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development
por: Goules, Andreas V., et al.
Publicado: (2020)

The clinical relevance of autoantibodies in scleroderma
por: Ho, Khanh T, et al.
Publicado: (2003)

Liver Fibrosis in Primary Sjögren’s Syndrome
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated Atherosclerosis
por: Kintrilis, Nikolaos, et al.
Publicado: (2021)

Vitamin D Deficiency in Primary Sjögren’s Syndrome: Association with Clinical Manifestations and Immune Activation Markers
por: Athanassiou, Panagiotis, et al.
Publicado: (2022)

Clinical phenotype in scleroderma patients based on autoantibodies
por: Santos, Cristiana Sieiro, et al.
Publicado: (2023)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Impaired Clearance of Early Apoptotic Cells Mediated by Inhibitory IgG Antibodies in Patients with Primary Sjögren's Syndrome
por: Manoussakis, Menelaos N., et al.
Publicado: (2014)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system
por: Skarlis, Charalampos, et al.
Publicado: (2018)

Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_das9a6vv1s6h5uksl0u1gi0gvt